Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D-PLEX 312 - Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two-arm, Double Blind Study to Assess Efficacy and Safety of D-PLEX In Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

NCT04411199 is registered in ClinicalTrials.gov with PolyPid Ltd. as lead sponsor.

NCT NCT04411199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04411199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D-PLEX 312 - Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two-arm, Double Blind Study to Assess Efficacy and Safety of D-PLEX In Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)
Lead sponsor
PolyPid Ltd.
Phase
Phase 3
Overall status
Completed
Start date
December 15, 2020
Completion date
May 10, 2025
Enrollment
975 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal surgery, colon surgery, post-op infection, surgical site infection